Mayo Clinic Laboratory and pathology research roundup: September 7
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: A delphi consensus statement.
There is a paucity of evidence to guide physicians regarding prevention strategies for cutaneous squamous cell carcinoma (CSCC) in solid organ transplant recipients (SOTRs). Via PubMed
Published to PubMed This Week
- Letter by Sandoval and Jaffe Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans".
- Anaplastic large-cell lymphoma (ALK-negative)-related heart failure and recurrence after heart transplantation.
Journal of Heart and Lung Transplantation
- Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study.
- Clinician perspectives on the use of artificial intelligence in inflammatory bowel disease.
- Envisioning future UTI diagnostics.
Clinical Infectious Disease
- AACC practical recommendations for implementing and interpreting SARS-CoV-2 emergency use authorization and laboratory-developed test serologic testing in clinical laboratories.
- Campylobacter jejuni genotypes are associated with post-infection irritable bowel syndrome in humans.
- Functional characterization of brain tumor-initiating cells and establishment of GBM preclinical models that incorporate heterogeneity, therapy, and sex differences.
Molecular Cancer Therapeutics
- Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody associated vasculitis.
Nephrology Dialysis Transplantation
- Surface color spectrophotometry in a murine model of steatosis: an accurate technique with potential applicability in liver procurement.